Dr. Wei-Chun HuangFu received her BSc from National Tsing-Hua University, her MSc from Duke University, and her PhD from North Carolina State University. She completed her postdoctoral training at the University of Pennsylvania, USA. She is currently an Associate Professor at the Graduate Institute of Cancer Biology and Drug Discovery and the Vice Dean for International Affairs of the College of Medical Science and Technology (CoMST) at Taipei Medical University, Taiwan. She is dedicated to drug discovery, drug pharmacology, and efficacy evaluation, as well as investigating their mechanism of action.

Academic Experience

Associate Professor, Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

Adjunct Associate Professor, Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University 

2013-2019 Assistant Professor, Graduate Institute of Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University

2007-2010 Postdoctoral Research Fellow, University of Pennsylvania, Philadelphia, PA, USA

Administrative Experience

2023- present Vice Dean for International Affairs, College of Medical Science and Technology, Taipei Medical University

2019-2020 Chief of International Research, Office of Global Engagement, Taipei Medical University

Drug Discovery for Cancers and Beyond 

We focus on developing novel small-molecule drugs for rare diseases and unmet clinical needs. We utilize an AI-assisted drug discovery platform to design and synthesize novel small molecules targeting specific disease targets including cancer and neurodegenerative diseases. This AI platform accelerates the drug discovery process, allowing us to quickly select drug candidates for development and provide help to those in need. My main responsibilities include drug pharmacology and efficacy evaluation and assisting in preclinical toxicology experiments.